1. Home
  2. CPSS vs MIST Comparison

CPSS vs MIST Comparison

Compare CPSS & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$8.99

Market Cap

201.5M

Sector

Finance

ML Signal

N/A

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

N/A

Current Price

$2.18

Market Cap

176.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPSS
MIST
Founded
1991
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.5M
176.3M
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
CPSS
MIST
Price
$8.99
$2.18
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
21.0K
9.9M
Earning Date
02-24-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.80
N/A
Revenue
$196,531,000.00
N/A
Revenue This Year
$139.62
N/A
Revenue Next Year
$10.58
N/A
P/E Ratio
$11.30
N/A
Revenue Growth
6.67
N/A
52 Week Low
$6.67
$0.63
52 Week High
$12.73
$3.06

Technical Indicators

Market Signals
Indicator
CPSS
MIST
Relative Strength Index (RSI) 48.98 50.42
Support Level $8.70 $1.98
Resistance Level $9.10 $2.25
Average True Range (ATR) 0.21 0.12
MACD -0.08 0.00
Stochastic Oscillator 28.72 82.82

Price Performance

Historical Comparison
CPSS
MIST

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: